HAMLET TO4 B — HAMLET Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for HAMLET Pharma AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Preliminary
Cash
Cash and Short Term Investments	39.6	18.4	23.1	10.8	5.09
Net Total Receivables	0.847	0.49	3.73	1.56	1.72
Prepaid Expenses
Total Other Current Assets
Total Current Assets	41.7	19	27.3	12.8	7.15
Net Property, Plant And Equipment	0	0	0.574	0.217	0.457
Net Intangible Assets
Total Assets	41.7	28.5	68.6	43.6	28.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.72	2.55	4.11	7.27	8.42
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.72	7.55	4.11	7.27	8.42
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38	20.9	64.5	36.3	19.7
Total Liabilities & Shareholders' Equity	41.7	28.5	68.6	43.6	28.1
Total Common Shares Outstanding